-
Epilepsy is associated with behavioral, psychiatric, cognitive, and social comorbidities. The associated comorbidities change across the lifespan of a person with epilepsy. Early detection and treatment of these comorbidities has the potential to significantly improve quality of life for patients with epilepsy.
-
Piriformis syndrome remains an elusive diagnosis and neurologists should avoid recommendations for surgery interventions.
-
-
Menopausal hormone therapy and risk of VTE and AD; patients' understanding of chemotherapy benefits; and FDA actions.
-
Diabetes mellitus is a risk factor for dementia, and poor glucose control is associated with worse cognitive function and greater decline.
-
A Simple Score Can Predict Outcome after Ischemic Stroke; Mismatch Between Perfusion and Diffusion on MRI Can Identify Good Candidates for Endovascular Reperfusion Therapy; Cerebral Microbleeds May Be Associated with Elevated Vascular Endothelial Growth Factor
-
Two recently reported Phase 3 trials for BG-12 demonstrated efficacy and safety in the treatment of relapsing-remitting multiple sclerosis.
-
Early seizures and EEG abnormalities as well as status epilepticus predicts worse outcome in SCN1A-positve Dravet syndrome in this new, large cohort of patients.
-
Dementia and benzodiazepines; effectiveness of omega-3 fatty acid and Ginkgo biloba supplements; and FDA actions.
-
Up to 50% of patients with seronegative ocular myasthenia gravis have antibodies to clustered acetylcholine receptor antibodies that can fix complement and passively transfer disease to experimental mice.